Page 1 of Clinical Trials for Drug Aldesleukin, 316 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
A Phase II Study of Lymphodepletion Followed by Autologous Tumor-Infiltrating Lymphocytes and High-Dose Adesleukin for Human Papillomavirus-Associated Cancers
Last Updated: May 3, 2012
Condition(s): Cervical Cancer; Oropharyngeal Cancer; Vaginal Cancer; Anal Cancer; Penile Cancer
2
Withdrawn
IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic Melanoma
Last Updated: January 25, 2012
Condition(s): Melanoma
3
Completed
Effect of Intermittent Aldesleukin Treatment With or Without Anti-HIV Drugs in HIV Infected People
Last Updated: April 9, 2012
Condition(s): HIV Infections
4
Completed
An International Study to Evaluate Recombinant Interleukin-2 (rIL-2) in HIV Positive Patients Taking Anti-retroviral Therapy
Last Updated: February 3, 2012
Condition(s): HIV Infections
5
Completed
Safety and Effectiveness of Adding Either an HIV Vaccine, Interleukin-2, or Both to a Patient's Anti-HIV Drug Combination
Last Updated: May 17, 2012
Condition(s): HIV Infections
6
Completed
A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3
Last Updated: April 24, 2012
Condition(s): HIV Infections
7
Not yet recruiting
A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection
Last Updated: April 23, 2009
Condition(s): HIV Infections
8
Completed
A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone
Last Updated: May 17, 2012
Condition(s): HIV Infections
9
Completed
Interleukin-2 (IL-2) Treatment for HIV Infected Patients Who Have Interrupted Their Anti-HIV Drug Therapy
Last Updated: May 9, 2012
Condition(s): HIV Infections
10
Completed
The Safety and Effectiveness of Interleukin-2 Plus Zidovudine in Patients With AIDS or AIDS Related Complex
Last Updated: April 25, 2012
Condition(s): HIV Infections
11
Recruiting
Study of Hydroxychloroquine and Aldesleukin in Renal Cell Carcinoma Patients (RCC)
Last Updated: March 15, 2012
Condition(s): Metastatic Renal Cell Carcinoma
12
Completed
Phase I Trial of the Combination of Zidovudine and Recombinant Interleukin-2 in Patients With Persistent Generalized Lymphadenopathy
Last Updated: April 24, 2012
Condition(s): HIV Infections
13
Completed
A Study of Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph Nodes
Last Updated: April 25, 2012
Condition(s): HIV Infections
14
Completed
Effect of Interleukin-2 on HIV Treatment Interruption
Last Updated: May 21, 2012
Condition(s): HIV Infections
15
Completed
Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection
Last Updated: May 21, 2012
Condition(s): HIV Infections; Hepatitis C
16
Terminated
Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma
Last Updated: April 17, 2008
Condition(s): Non-Hodgkin's Lymphoma
17
Active, not recruiting
Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Patients With Advanced Solid Tumors
Last Updated: September 20, 2011
Condition(s): Neoplasms; Tumors; Solid Tumors; Metastatic Cancer
18
Completed
A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis
Last Updated: June 23, 2005
Condition(s): Cytomegalovirus Retinitis; HIV Infections
19
Completed
Aldesleukin in Patients With Metastatic Renal Cell Carcinoma and Metastatic Melanoma
Last Updated: April 27, 2012
Condition(s): Metastatic Renal Cell Carcinoma; Metastatic Melanoma
20
Not yet recruiting
IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma
Last Updated: February 3, 2012
Condition(s): Melanoma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Aldesleukin

Page 1 of Clinical Trials for Drug Aldesleukin, 316 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About